Albeit it was not fully understood when we were caught off-guard with the first-known outbreak of SARS in 2002 in Guangzhou, PRC, the structural similarity of its Spike 2 protein to HIV-1 was confirmed two years later, contrary to the original symptomatic naming scheme. In the first Questions of COVID-19 book, I have expressed my doubts on the virus corresponding better to the negative-sense paramyxovirus instead of the positive-sense, single-stranded coronavirus; for whatever the academic debates are worth, I don't have to argue for the recognition on the autoimmune disease nature of the wrongfully labeled COVID-19.

Global phenomena require global explanations, even when single-country analyses can provide the most lucid causal picture. In the second volume of the book series, I don't mean to dig again too much into the crimes behind the institutional derogations in public health, nor into the mass psychology impacts that deny us of the truths, but some pragmatic solutions for me to offer with the clinical trial interventions.

. .